The medicinal hub of Bombay , India , has emerged as a crucial center for the production of Tetrabenazine API (CAS No. 58-46-8). Several trusted organizations are specializing in the manufacturing of this critical active pharmaceutical ingredient. These players often deliver Tetrabenazine to both the local and foreign markets, adhering to stringent